At BeiGene, we’re committed to improving access to and diversity in clinical trials, knowing there are many barriers hindering participation in trials. Our extensive internal development team allows us to run clinical trials in-house, reducing the cost and improving the speed of drug development by up to 30%, and creating a broader clinical footprint that gets our medicines to more people across the world.
BeiGene, a global oncology company: www.beigene.com/